Medigus is a medical device company specializing in developing minimally invasive endosurgical tools and highly innovative imaging solutions across medical and industrial applications.
Our vision is to enhance the advantages of disposable endoscopes and miniaturized direct vision systems to help improve patient outcomes and their quality of lives.
Our mission is to become the industry leader in the development and manufacturing of single-use video endoscopes for the diagnosis or treatment of widespread GI diseases.
We are the pioneer developer of the Medigus Ultrasonic Surgical Endostapler, or MUSE™ system, a unique proprietary endoscopic device for the treatment of gastroesophageal reflux disease (GERD), one of the most common chronic diseases in the western world.
The MUSE system, our flagship medical device, addresses the unmet need in between drug therapy and invasive surgery for the long-term treatment of GERD (gastroesophageal reflux disease), commonly referred to as acid reflux.
We have also developed a range of micro video cameras under our micro ScoutCam™ portfolio of products, including the micro ScoutCam 1.2, which to the best of the company's knowledge, is the smallest in the world.
Our innovative micro cameras are suitable for both medical and industrial applications and can be customized to meet a range of needs across both applications. In fact, we design and manufacture endoscopy and micro camera systems for some of the biggest medical and industrial companies in the world.
Learn more about our full range of CMOS (complementary metal-oxide semiconductor) and CCD (charge-coupled device) by visiting www.microscoutcam.com.
Medigus stock is traded in the U.S. on the Nasdaq and in Israel on the Tel Aviv Stock Exchange (TASE) under the ticker “MDGS”.